Bolder biotech investments, not less, is key to better health outcomes for all
The goal is expanding access to drugs and the types of patients that can benefit from treatments.
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
HEALTHCARE costs are rising globally. This is driven by ageing populations, lifestyle demographic shifts, newer treatments being offered, and a skilled manpower shortage.
Since the Covid-19 pandemic, inflationary pressures have been experienced across the healthcare industry. The WTW Global Medical Trends Survey projects more than 10 per cent increase in medical costs in 2025.
Yet, evidence of an association between healthcare costs and quality outcomes is inconsistent.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
Near sell-out launches in March boost developer sales to 1,300 units after four slow months
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025
